Liver Cancer News and Research RSS Feed - Liver Cancer News and Research

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.
NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

NASPGHAN clinical practice guidelines recommend screening test for NAFLD in obese children

A screening test for non-alcoholic fatty liver disease (NAFLD)--a serious condition that may have lifelong health consequences--is recommended for all obese children aged nine to eleven years, according to clinical practice guidelines developed by the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition and published in the Journal of Pediatric Gastroenterology and Nutrition. [More]
New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

New green nanotechnology approach targets, destroys precancerous tumor cells in livers of mice

According to the American Cancer Society, more than 700,000 new cases of liver cancer are diagnosed worldwide each year. [More]
Research provides insight into molecular mechanisms involved in immune response to HBV

Research provides insight into molecular mechanisms involved in immune response to HBV

The innate immune system in mammals defends against infection from viruses and other microbial infections. [More]
Low-calorie diet and exercise could improve kidney function in patients with NASH

Low-calorie diet and exercise could improve kidney function in patients with NASH

Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. [More]
New public-private partnership launches major health effort to reduce cancer in San Francisco

New public-private partnership launches major health effort to reduce cancer in San Francisco

Cancer is the leading cause of death in San Francisco and costs patients, families and taxpayers hundreds of millions of dollars each year. [More]
Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Study finds way to increase liver cancer screening rates among at-risk cirrhosis patients

Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found. [More]
Alcohol to cause 135,000 cancer deaths over next 20 years, news report reveals

Alcohol to cause 135,000 cancer deaths over next 20 years, news report reveals

Alcohol will cause around 135,000 cancer deaths over the next 20 years and will cost the NHS an estimated £2 billion in treatments, according to estimates from a new report by Sheffield University, commissioned by Cancer Research UK. [More]
Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

Hepatitis C virus sabotages antiviral defenses of liver cells by blunting effect of immune proteins

The virus that causes hepatitis C protects itself by blocking signals that call up immune defenses in liver cells, according to University of Washington researchers and colleagues reporting Nov. 14 in Nature Medicine. [More]
HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

HCV patients treated with DAA therapy not at increased risk of developing liver cancer, study finds

A new study presented this week at The Liver Meeting — held by the American Association for the Study of Liver Diseases — found patients with hepatitis C who take direct-acting antiviral medication are at no higher risk for developing liver cancer than those who do not take the medication. [More]
Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

Targeted precision medicine can eliminate cancer risk in patients with Type 2 diabetes

The links between Type 2 diabetes and cancer are complex: people suffering from diabetes mellitus essentially have a higher risk of developing cancer but, on top of that, some diabetes drugs are also suspected of increasing the risk in some cases. [More]
New treatment can halt growth of liver cancer cells, research shows

New treatment can halt growth of liver cancer cells, research shows

Scientists have shown that a mutation in a gene called Arid1b can cause liver cancer. The gene normally protects against cancer by limiting cell growth, but when mutated it allows cells to grow uncontrollably. [More]
Researchers develop new lab technique that may aid development of anti-cancer treatment

Researchers develop new lab technique that may aid development of anti-cancer treatment

RESEARCHERS at the University of Huddersfield have developed a new lab technique that may aid the development and success rate of an important anti-cancer treatment. [More]
Turning off TAZ protein in liver cells reverses fibrosis in mice

Turning off TAZ protein in liver cells reverses fibrosis in mice

Scientists at Columbia University Medical Center have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease that can lead to liver failure. [More]
New minimally invasive surgery may soon be viable alternative to treat liver cancer

New minimally invasive surgery may soon be viable alternative to treat liver cancer

For patients who may benefit from a major liver operation to treat cancer, an open abdominal procedure is often the only option. [More]
Japanese researchers identify mechanism for hormone that limits liver fibrosis

Japanese researchers identify mechanism for hormone that limits liver fibrosis

Nonalcoholic steatohepatitis (NASH) has been emerging worldwide and effective treatment, especially for liver fibrosis, is essential for improving the prognosis. [More]
Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

Common drug for allergies and asthma could prevent fibrosis, reduce need for liver transplants

A drug commonly used for the prevention of allergies and asthma someday could find new use in preventing liver disease and reducing the need for transplants, according to new research published in the October 2016 edition of the scientific journal Hepatology. [More]
Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Community outreach workers may help increase HBV vaccination rates to cut risk of liver cancer

Liver cancer is more common among Asian Americans in part because they are at high risk of HBV infection. [More]
Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

Novel method can quantify progression of NAFLD to more advanced fibrosis and cirrhosis

Combining multiple non-invasive measures, researchers at University of California San Diego School of Medicine describe a novel method to quantify the progression of nonalcoholic fatty liver disease (NAFLD) to its more dangerous and deadly states — advanced fibrosis and cirrhosis. [More]
Research findings provide new avenues to target virus infection

Research findings provide new avenues to target virus infection

Viral infection is one of the leading medical challenges of the 21st Century, ranging from the Hepatitis C Virus (HCV) epidemic affecting 3% of the global population, to recent outbreaks of West Nile, Zika, and Ebola viruses. [More]
MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

MU researcher awarded $3 million NIH grant to develop new drugs for treating HBV

Hepatitis B (HBV) is a viral infection that increases the likelihood of developing liver cancer or liver failure. [More]
Advertisement